SEQUENOM Announces Launch of MassARRAY Compact 96 System
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: 1 minute
SEQUENOM, Inc. has announced the launch of the MassARRAY® Compact 96 system. This generation of the MassARRAY system now addresses the needs of lower throughput laboratories.
The combination of features of the new MassARRAY Compact 96 system and ability to run fewer samples - make this an ideal system for use in basic and clinical laboratories, the company claims.
With the addition of the MassARRAY Compact 96 system SEQUENOM now offers genetic analysis solutions to serve the needs of any sized laboratory.
The MassARRAY Compact 96 system delivers:
• exceptional performance which makes it ideal for the most demanding applications; and
• highly sensitive and specific mass spec-based detection of low frequency mutations that are typically undetected using conventional techniques.
The technology allows researchers to generate assays against any biomarkers they desire to validate, and to easily make changes to assays and biomarkers throughout the validation process.
MassARRAY technology supports key genomic applications, including single nucleotide polymorphism (SNP) genotyping, quantitative gene expression, and copy number variation (CNV) analysis, providing a multi-faceted view of a researcher's biological system of interest.
"Replacing other platforms that are limited to looking at tens of samples per week, our range of MassARRAY system products now allows for the analysis of hundreds through thousands of samples per day," said Mike Monko, senior vice president of sales & marketing at SEQUENOM.
"MassARRAY technology enables detection of the most common molecular biomarker classes - somatic mutations via the OncoCarta mutation panel, SNPs, CNVs, methylation patterns, expression signatures - with an unmatched combination of quantitative accuracy and sensitivity. This is the type of high data quality that can potentially push biomarkers to clinical utilization and make the promise of personalized medicine a reality."
The combination of features of the new MassARRAY Compact 96 system and ability to run fewer samples - make this an ideal system for use in basic and clinical laboratories, the company claims.
With the addition of the MassARRAY Compact 96 system SEQUENOM now offers genetic analysis solutions to serve the needs of any sized laboratory.
The MassARRAY Compact 96 system delivers:
• exceptional performance which makes it ideal for the most demanding applications; and
• highly sensitive and specific mass spec-based detection of low frequency mutations that are typically undetected using conventional techniques.
The technology allows researchers to generate assays against any biomarkers they desire to validate, and to easily make changes to assays and biomarkers throughout the validation process.
MassARRAY technology supports key genomic applications, including single nucleotide polymorphism (SNP) genotyping, quantitative gene expression, and copy number variation (CNV) analysis, providing a multi-faceted view of a researcher's biological system of interest.
"Replacing other platforms that are limited to looking at tens of samples per week, our range of MassARRAY system products now allows for the analysis of hundreds through thousands of samples per day," said Mike Monko, senior vice president of sales & marketing at SEQUENOM.
"MassARRAY technology enables detection of the most common molecular biomarker classes - somatic mutations via the OncoCarta mutation panel, SNPs, CNVs, methylation patterns, expression signatures - with an unmatched combination of quantitative accuracy and sensitivity. This is the type of high data quality that can potentially push biomarkers to clinical utilization and make the promise of personalized medicine a reality."
